Beyond the known targets of YAP (i.e., MYC and CCND1), we uncovered TRAM2 (translocation chain-associated membrane 2) and described its contribution to cellular proliferation, epithelial to mesenchymal transition (EMT), and cellular migration and invasion, as well as cancer prognosis. The gene discussed is CCND1; the disease is cancer.